Clinical Trials Directory

Trials / Completed

CompletedNCT05288088

Why Still in Neurosurgical Ward After Tumor Craniotomy?

Factors Associated With Prolonged In-hospital Stay After Elective Tumor Craniotomy.

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Rigshospitalet, Denmark · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of this prospective observational study is to identify the specific reasons that prolong a hospital stay after elective tumor craniotomy. Optimal postoperative in-hospital stay is considered to be two days from surgery to discharge from the neurosurgical ward. However, a variable length of stay at a neurological department for follow-up of late recognized deficits of neurological consequences of the surgical procedure are common.

Detailed description

The concept of fast-track surgery and later enhanced recovery after surgery (ERAS) was first imputed in 1990s. Since then, ERAS protocols have been successfully adopted in many surgical fields, often with dramatic benefits for the patients. Length of hospital stay is one of the main questions addressed in many ERAS studies, as it by a simple approach address many of the complications encountered by the patients or the case flow in the perioperative period. Why patients have prolonged hospital stay after surgery has been investigated by Husted et al. in 2011 after hip and knee arthroplasty and P. Munk-Madsen et al. in 2019 after laparoscopic colorectal surgery. Both studies could isolate dominating factors prolonging hospital stay, some of them preventable. Existing length of stay studies on tumor craniotomy patients have focused on specific variables affecting hospital duration, but never explored the true cause of prolonged hospitalization.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTNo interventionThis is an observational study

Timeline

Start date
2022-06-12
Primary completion
2023-06-28
Completion
2023-11-15
First posted
2022-03-18
Last updated
2023-11-18

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT05288088. Inclusion in this directory is not an endorsement.